<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04731012</url>
  </required_header>
  <id_info>
    <org_study_id>ED-S</org_study_id>
    <nct_id>NCT04731012</nct_id>
  </id_info>
  <brief_title>Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies</brief_title>
  <official_title>Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators conduct a study to evaluate the underlying causes of preeclampsia in&#xD;
      oocyte-donation pregnancies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A detailed medical history, questionnaires as well as blood, urine and placental samples will&#xD;
      be used to analyse several factors leading to the high risk of preeclampsia in&#xD;
      oocyte-donation pregnancies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Preeclampsia in oocyte-donation pregnancies is caused by an altered composition of immune cells in placenta and blood.</measure>
    <time_frame>01.01.2020 - 01.12.2025</time_frame>
    <description>T-Cell populations are altered in preeclampsia. HLA-mismatch of mother and donor oocyte lead to a &quot;host-versus-graft&quot; reaction. T-, B- and Natural killer cells are altered in placental tissue of oocyte-donation pregnancies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preeclampsia in oocyte-donation pregnancies is caused by an activation of pro-inflammatory factors and endothelial dysfunction.</measure>
    <time_frame>01.01.2020 - 01.12.2025</time_frame>
    <description>Altered Natural killer cells and B-cells in oocyte-donation pregnancies lead to endothelial dysfunction. Pro-inflammatory factors are higher in OD pregnancy and can be measured in placental tissue via single-cell sequencing.</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Oocyte-donation Pregnancies</condition>
  <arm_group>
    <arm_group_label>healthy oocyte-donation pregnancy</arm_group_label>
    <description>healthy pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>preeclamptic oocyte-donation pregnancy</arm_group_label>
    <description>preeclampsia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy IVF or ICSI pregnancy</arm_group_label>
    <description>healthy pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>preeclamptic IVF or ICSI pregnancy</arm_group_label>
    <description>preeclampsia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy spontaneous conception pregnancy</arm_group_label>
    <description>healthy pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>preeclamptic spontaneous conception pregnancy</arm_group_label>
    <description>preeclampsia</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        -  oocyte donation pregnancies&#xD;
&#xD;
          -  IVF or ICSI pregnanies&#xD;
&#xD;
          -  spontaneous conception pregnancies&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe auto immune disorders&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Florian Herse, DSc</last_name>
    <phone>+49 30 450 540 434</phone>
    <email>florian.herse@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Judith Altmann, MD</last_name>
    <email>judith.altmann@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Experimental and Clinical Research Center (ECRC)</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Herse, PhD</last_name>
      <phone>+49 30 450 540 434</phone>
      <email>florian.herse@charite.de</email>
    </contact>
    <investigator>
      <last_name>Florian Herse, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Florian Herse</investigator_full_name>
    <investigator_title>Doctor of Science</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

